• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤屏障界面处的鞘氨醇-1-磷酸信号传导

Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface.

作者信息

Masuda-Kuroki Kana, Di Nardo Anna

机构信息

Department of Dermatology, School of Medicine, University of California, San Diego, CA 92093, USA.

出版信息

Biology (Basel). 2022 May 25;11(6):809. doi: 10.3390/biology11060809.

DOI:10.3390/biology11060809
PMID:35741330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9219813/
Abstract

Sphingosine 1-phosphate (S1P) is a product of membrane sphingolipid metabolism. S1P is secreted and acts via G-protein-coupled receptors, S1PR1-5, and is involved in diverse cellular functions, including cell proliferation, immune suppression, and cardiovascular functions. Recent studies have shown that the effects of S1P signaling are extended further by coupling the different S1P receptors and their respective downstream signaling pathways. Our group has recently reported that S1P inhibits cell proliferation and induces differentiation in human keratinocytes. There is a growing understanding of the connection between S1P signaling, skin barrier function, and skin diseases. For example, the activation of S1PR1 and S1PR2 during bacterial invasion regulates the synthesis of inflammatory cytokines in human keratinocytes. Moreover, S1P-S1PR2 signaling is involved in the production of inflammatory cytokines and can be triggered by epidermal mechanical stress and bacterial invasion. This review highlights how S1P affects human keratinocyte proliferation, differentiation, immunoreaction, and mast cell immune response, in addition to its effects on the skin barrier interface. Finally, studies targeting S1P-S1PR signaling involved in inflammatory skin diseases are also presented.

摘要

1-磷酸鞘氨醇(S1P)是膜鞘脂代谢的产物。S1P被分泌出来并通过G蛋白偶联受体S1PR1 - 5发挥作用,参与多种细胞功能,包括细胞增殖、免疫抑制和心血管功能。最近的研究表明,通过耦合不同的S1P受体及其各自的下游信号通路,S1P信号的作用得到了进一步扩展。我们小组最近报道,S1P抑制人角质形成细胞的增殖并诱导其分化。人们对S1P信号、皮肤屏障功能和皮肤疾病之间的联系的认识正在不断加深。例如,在细菌入侵期间S1PR1和S1PR2的激活调节人角质形成细胞中炎性细胞因子的合成。此外,S1P - S1PR2信号传导参与炎性细胞因子的产生,并且可由表皮机械应激和细菌入侵触发。这篇综述重点介绍了S1P如何影响人角质形成细胞的增殖、分化、免疫反应和肥大细胞免疫反应,以及它对皮肤屏障界面的影响。最后,还介绍了针对炎性皮肤病中涉及的S1P - S1PR信号传导的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/9b91815f485d/biology-11-00809-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/dc1d14a9e4bc/biology-11-00809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/c635ed5fb12b/biology-11-00809-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/3938db5006bc/biology-11-00809-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/9b91815f485d/biology-11-00809-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/dc1d14a9e4bc/biology-11-00809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/c635ed5fb12b/biology-11-00809-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/3938db5006bc/biology-11-00809-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf24/9219813/9b91815f485d/biology-11-00809-g004.jpg

相似文献

1
Sphingosine 1-Phosphate Signaling at the Skin Barrier Interface.皮肤屏障界面处的鞘氨醇-1-磷酸信号传导
Biology (Basel). 2022 May 25;11(6):809. doi: 10.3390/biology11060809.
2
Human Keratinocytes Use Sphingosine 1-Phosphate and its Receptors to Communicate Staphylococcus aureus Invasion and Activate Host Defense.人角质形成细胞利用鞘氨醇 1-磷酸及其受体来传递金黄色葡萄球菌入侵并激活宿主防御。
J Invest Dermatol. 2019 Aug;139(8):1743-1752.e5. doi: 10.1016/j.jid.2019.02.010. Epub 2019 Feb 23.
3
Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.肿瘤抑制型鞘氨醇-1-磷酸受体-2 拮抗肿瘤促进型鞘氨醇-1-磷酸受体-1 和鞘氨醇激酶 1——藏在幕后的海德。
Am J Cancer Res. 2011;1(4):460-81. Epub 2011 Feb 16.
4
The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases.鞘氨醇-1-磷酸在肠道黏膜微环境及炎症性肠病中的作用
Front Physiol. 2023 Jul 25;14:1235656. doi: 10.3389/fphys.2023.1235656. eCollection 2023.
5
Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts.鞘氨醇-1-磷酸/S1PR2介导的信号传导触发Smad1/5/8磷酸化,从而诱导成骨细胞中Runx2的表达。
Bone. 2016 Dec;93:1-11. doi: 10.1016/j.bone.2016.09.003. Epub 2016 Sep 6.
6
The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses.1-磷酸鞘氨醇/1-磷酸鞘氨醇受体2轴在小鼠肥大细胞依赖性急性过敏反应中调节早期气道T细胞浸润。
J Allergy Clin Immunol. 2015 Apr;135(4):1008-1018.e1. doi: 10.1016/j.jaci.2014.10.044. Epub 2014 Dec 13.
7
Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.系统性硬化症和肺动脉高压中鞘氨醇-1-磷酸受体的自身免疫。
Front Immunol. 2022 Jul 4;13:935787. doi: 10.3389/fimmu.2022.935787. eCollection 2022.
8
Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells.不同剂量的1-磷酸鞘氨醇刺激内皮细胞后受体和信号通路的差异激活
Exp Physiol. 2015 Jan;100(1):95-107. doi: 10.1113/expphysiol.2014.082149. Epub 2014 Dec 2.
9
Sphingosine 1-Phosphate: A Novel Target for Lung Disorders.鞘氨醇-1-磷酸:肺部疾病的新靶点。
Front Immunol. 2017 Mar 14;8:296. doi: 10.3389/fimmu.2017.00296. eCollection 2017.
10
Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases.鞘氨醇-1-磷酸作为炎症性皮肤疾病中的必需信号分子。
Int J Mol Sci. 2023 Jan 11;24(2):1456. doi: 10.3390/ijms24021456.

引用本文的文献

1
Comparative transcriptomic analysis reveals breed-specific developmental characters of skin and feather follicles between Anser Cygnoides and Anser Anser.比较转录组分析揭示了鸿雁和灰雁之间皮肤和毛囊的品种特异性发育特征。
Poult Sci. 2025 Jun 28;104(10):105457. doi: 10.1016/j.psj.2025.105457.
2
G-Protein-Coupled Receptors in Chronic Kidney Disease Induced by Hypertension and Diabetes.高血压和糖尿病所致慢性肾脏病中的G蛋白偶联受体
Cells. 2025 May 16;14(10):729. doi: 10.3390/cells14100729.
3
Lipid Dysregulation in Sebaceous Gland Disorders and the Impact of Sphingolipid Metabolism on Acne Pathogenesis.

本文引用的文献

1
The lncRNA H19/miR-766-3p/S1PR3 Axis Contributes to the Hyperproliferation of Keratinocytes and Skin Inflammation in Psoriasis via the AKT/mTOR Pathway.长链非编码 RNA H19/miR-766-3p/S1PR3 轴通过 AKT/mTOR 通路促进银屑病角质形成细胞过度增殖和皮肤炎症。
Mediators Inflamm. 2021 Dec 28;2021:9991175. doi: 10.1155/2021/9991175. eCollection 2021.
2
Signaling through the S1P-S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment.鞘氨醇-1-磷酸-鞘氨醇-1-磷酸受体轴在肠道、免疫及中枢神经系统中的信号传导与多发性硬化症:对发病机制及治疗的意义
Cells. 2021 Nov 18;10(11):3217. doi: 10.3390/cells10113217.
3
皮脂腺疾病中的脂质失调以及鞘脂代谢对痤疮发病机制的影响。
Cureus. 2025 Apr 17;17(4):e82463. doi: 10.7759/cureus.82463. eCollection 2025 Apr.
4
Inhibition of Sphingosine-1-Phosphate Receptor 2 (S1P) Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.抑制鞘氨醇-1-磷酸受体2(S1P)可减轻咪喹莫特诱导的BALB/c小鼠银屑病样皮肤炎症。
Biomol Ther (Seoul). 2025 May 1;33(3):544-553. doi: 10.4062/biomolther.2024.197. Epub 2025 Apr 23.
5
Pilot Study on the Effects of a Cosmetic Serum Containing Niacinamide, Postbiotics and Peptides on Facial Skin in Healthy Participants: A Randomized Controlled Trial.含烟酰胺、后生元及肽的美容精华液对健康受试者面部皮肤影响的初步研究:一项随机对照试验
Life (Basel). 2024 Dec 18;14(12):1677. doi: 10.3390/life14121677.
6
S1PR1 mediates Th17 cell migration from the thymus to the skin in health and disease.S1PR1 介导 Th17 细胞从胸腺向皮肤的迁移,在健康和疾病中均如此。
Front Immunol. 2024 Sep 23;15:1473130. doi: 10.3389/fimmu.2024.1473130. eCollection 2024.
7
Amelioration of Fibrosis via S1P Inhibition Is Regulated by Inactivation of TGF-β and SPL Pathways in the Human Cornea.通过抑制 S1P 来改善纤维化是通过在人角膜中失活 TGF-β和 SPL 途径来调节的。
Int J Mol Sci. 2024 Jun 14;25(12):6560. doi: 10.3390/ijms25126560.
8
Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology.转录组学分析揭示了航天皮肤病学背后的分子改变。
Commun Med (Lond). 2024 Jun 11;4(1):106. doi: 10.1038/s43856-024-00532-9.
9
Ceramides are fuel gauges on the drive to cardiometabolic disease.神经酰胺是通向心脏代谢疾病的燃料表。
Physiol Rev. 2024 Jul 1;104(3):1061-1119. doi: 10.1152/physrev.00008.2023. Epub 2024 Feb 1.
10
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents.治疗银屑病的新兴口服疗法:在研药物综述
Pharmaceutics. 2024 Jan 15;16(1):111. doi: 10.3390/pharmaceutics16010111.
Novel functions of S1P in chronic itchy and inflammatory skin diseases.
鞘氨醇-1-磷酸在慢性瘙痒和炎症性皮肤病中的新功能。
J Eur Acad Dermatol Venereol. 2022 Mar;36(3):365-372. doi: 10.1111/jdv.17764. Epub 2021 Nov 12.
4
Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes.鞘氨醇 1-磷酸受体 5(S1PR5)调节组织驻留淋巴细胞在外周的滞留。
J Exp Med. 2022 Jan 3;219(1). doi: 10.1084/jem.20210116. Epub 2021 Oct 22.
5
Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition.脂质受体 S1PR1 和 S1PR5 的信号复合物结构揭示了激活和药物识别的机制。
Cell Res. 2021 Dec;31(12):1263-1274. doi: 10.1038/s41422-021-00566-x. Epub 2021 Sep 15.
6
The S1PR1 agonist SEW2871 promotes the survival of skin flap.S1PR1激动剂SEW2871可促进皮瓣存活。
Can J Physiol Pharmacol. 2021 Dec;99(12):1280-1287. doi: 10.1139/cjpp-2021-0006. Epub 2021 Jul 26.
7
Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.芬戈莫德通过在次级淋巴器官中隔离产生白细胞介素-17 的?d T 细胞来改善咪喹莫特诱导的银屑病样皮炎。
J Dermatol Sci. 2021 May;102(2):116-125. doi: 10.1016/j.jdermsci.2021.04.004. Epub 2021 Apr 15.
8
Suppressive Effect of CYM50358 S1P Antagonist on Mast Cell Degranulation and Allergic Asthma in Mice.CYM50358(一种鞘氨醇-1-磷酸拮抗剂)对小鼠肥大细胞脱颗粒及过敏性哮喘的抑制作用
Biomol Ther (Seoul). 2021 Sep 1;29(5):492-497. doi: 10.4062/biomolther.2020.206.
9
Sphingosine 1-Phosphate Receptor 2 Is Central to Maintaining Epidermal Barrier Homeostasis.鞘氨醇-1-磷酸受体2对维持表皮屏障稳态至关重要。
J Invest Dermatol. 2021 May;141(5):1188-1197.e5. doi: 10.1016/j.jid.2020.09.026. Epub 2020 Nov 14.
10
A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.一种新型选择性鞘氨醇激酶 2 抑制剂 HWG-35D 通过阻断初始 CD4 T 淋巴细胞向 Th17 分化改善咪喹莫特诱导的银屑病模型的严重程度。
Int J Mol Sci. 2020 Nov 8;21(21):8371. doi: 10.3390/ijms21218371.